The concept of innovative drugs remains active, with Xintian Pharma and others hitting the daily limit
The concept of innovative drugs continues to be active, with Xintian Pharma, Fuyuan Pharmaceutical, CheezhengTTM, JLPC, and HSGC hitting the daily limit, Guanhao Biotech rising over 13%, and ALK rising over 9%